<?xml version="1.0" encoding="UTF-8"?>
<ref id="B139">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ogawa</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Morisada</surname>
    <given-names>A.</given-names>
   </name>
  </person-group> (
  <year>2002</year>). 
  <article-title>Novel mode of action of ribavirin (Rebetol®), a drug for the treatment of chronic hepatitis C: inducting the mutation of RNA viruses</article-title>. 
  <source>Folia Pharmacol. Jpn.</source>
  <volume>120</volume>, 
  <fpage>398</fpage>–
  <lpage>408</lpage>. 
  <pub-id pub-id-type="doi">10.1254/fpj.120.398</pub-id>
  <?supplied-pmid 12528471?>
  <pub-id pub-id-type="pmid">12528471</pub-id>
 </mixed-citation>
</ref>
